Literature DB >> 3861611

The genetics of Graves' disease: HLA and disease susceptibility.

V Stenszky, L Kozma, C Balázs, S Rochlitz, J C Bear, N R Farid.   

Abstract

To relate genetic variation in Graves' disease (GD) susceptibility to polymorphism at MHC loci, clinical and family studies were undertaken in eastern Hungary. Among 1980 relatives of 534 index patients, 2.9% of siblings, 2.7% of offspring, and 3.0% of parents had GD. HLA haplotype combinations in affected sibling pairs were determined in the present data and combined with data in the literature (12 sibling pairs from Farid 1981, 12 from Chan et al. 1980, and 15 from Sasazuki et al. 1983); 43, 23, and 1 affected sibling pairs shared, respectively, 2, 1, and 0 HLA haplotypes. This distribution is inconsistent with simple dominant inheritance, but is consistent with simple recessive inheritance of HLA-related susceptibility over a range of gene frequencies (0.2-0.4). A frequency of 0.3 gives the best fit and is consistent with penetrance of 7.1% for the recessive susceptibility genotype; the data, however, can accommodate penetrance values up to 16%. The distribution of HLA haplotypes in 33 families related disease susceptibility more strongly to DR than to other loci. The distribution of HLA-B8 genotypes in 256 patients was in close agreement with Hardy-Weinberg equilibrium proportions, also favoring recessive inheritance of MHC-related susceptibility. The probability that an individual will be affected with GD can be predicted, based on sex, HLA genotype, and family history. For example, 14.9% of DR3-positive women with an affected first degree relative are likely to be affected. These predictions can be tested as family data accumulate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861611     DOI: 10.1210/jcem-61-4-735

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Genetics of thyroid-associated ophthalmopathy: a play in search of a cast of characters.

Authors:  N R Farid; M Marga
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

2.  HLA-DRB3 gene alleles in Caucasian patients with Graves' disease.

Authors:  B O Boehm; P Kühnl; B J Manfras; M Chen; J C Lee; G Holzberger; S Seidl; E Schifferdecker; P M Schumm-Draeger; K H Usadel
Journal:  Clin Investig       Date:  1992-10

3.  Immunogenetic markers in patients with Graves' disease.

Authors:  E Schifferdecker; P Kühnl; K Schöffling; B Manfras; G Holzberger; W Spielmann; B O Böhm
Journal:  Klin Wochenschr       Date:  1991-04-04

4.  Exon 33 T/T genotype of the thyroglobulin gene is a susceptibility gene for Graves' disease in Taiwanese and exon 12 C/C genotype protects against it.

Authors:  Jeng-Yueh Hsiao; Ming-Chia Hsieh; Kai-Jen Tien; Shih-Chie Hsu; Shiu-Ru Lin; Der-Shin Ke
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

5.  Current concepts in graves' disease.

Authors:  Christian M Girgis; Bernard L Champion; Jack R Wall
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

6.  Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families.

Authors:  Yaron Tomer; Yoshiyuki Ban; Erlinda Concepcion; Giuseppe Barbesino; Ronald Villanueva; David A Greenberg; Terry F Davies
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

Review 7.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 8.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

9.  Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease.

Authors:  Yoshiyuki Ban; David A Greenberg; Erlinda Concepcion; Lucy Skrabanek; Ronald Villanueva; Yaron Tomer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 10.  Interferon induced thyroiditis.

Authors:  Yaron Tomer; Francesca Menconi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.